Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Benlysta 120 mg powder for concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
belimumab
Company:  
GlaxoSmithKline UK See contact details
ATC code: 
L04AA26
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Live Chat HCP Med Info
{arrow_left}
{arrow_right}

This chat facility is provided by the company that holds the marketing authorisation for the medicine


Click here to connect to Chat

Click to Chat is a service provided for healthcare professionals and patients, you can use the chat facility to contact GSK about prescription only medicines.

Click to chat is open during the hours of 9.00am - 5.00pm Mon-Fri.

Ref UK/OTH/0012/16(1) August 2018
GlaxoSmithKline UK
Company image
Address
79 New Oxford Street, London, WC1A 1DG, UK
Telephone
0800 221 441
Medical Information e-mail
[email protected]
E-mail
[email protected]
Adverse event reporting email
[email protected]